Picture of AprilBio Co logo

397030 AprilBio Co Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual income statement for AprilBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUSAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue150023,3962000
Cost of Revenue
Gross Profit150023,396
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses3,0729,18818,95011,66413,385
Operating Profit-2,922-9,1884,446-11,464-13,385
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-4,776-10,344-52,713-8,959-14,130
Provision for Income Taxes
Net Income After Taxes-4,823-10,220-52,713-8,959-14,130
Net Income Before Extraordinary Items
Net Income-4,823-10,220-52,713-8,959-14,130
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-4,823-10,220-52,713-8,959-14,130
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-229-486-2,507-458-661
Dividends per Share